Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Effectiveness and Tolerability of Tapentadol Hydrochloride Prolonged Release, and Tapentadol Hydrochloride Immediate Release on Demand, in Subjects With Severe Chronic Nociceptive, Mixed or Neuropathic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability

NCT00986258 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT00986258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00986258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Effectiveness and Tolerability of Tapentadol Hydrochloride Prolonged Release, and Tapentadol Hydrochloride Immediate Release on Demand, in Subjects With Severe Chronic Nociceptive, Mixed or Neuropathic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability
Lead sponsor
Grünenthal GmbH
Phase
Phase 3
Overall status
Terminated
Start date
October 30, 2009
Completion date
January 31, 2011
Enrollment
136 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, low back pain, neuropathic pain, nociceptive pain, pain